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Background: It is unknown whether reverse remodeling with heart failure (HF) therapies is affected by diabetes mellitus (DM). We studied the 
effect of DM on reverse remodeling and outcomes with cardiac resynchronization therapy (CRT) in NYHA class I-II HF.
Methods: Subjects with stage C HF, LVEF ≤40%, LV end-diastolic dimension ≥55 mm, QRS ≥120 ms, and NYHA class I-II HF symptoms on optimal 
medical therapy received CRT ± ICD and were randomized to CRT-ON or OFF for 12 months. Change in left ventricular end-systolic volume index 
(ΔLVESVI) and other remodeling measures was compared between diabetics (D) and non-diabetics (ND) randomized to CRT-ON. Analysis was done 
with t-tests of difference estimates from repeated measures ANOVA with subject as a random effect, and time, DM and interaction as fixed effects. 
Multivariate analysis was used to adjust for baseline characteristics. Rates of death and HF hospitalization in D and ND were compared at 12 
months using Fisher’s exact test.
Results: In REVERSE, 91 D and 328 ND were randomized to CRT-ON. At baseline, D were more often ischemic and had larger LVESVI. DM was 
associated with smaller ΔLVESVI with CRT (D: -8.9 mL/m2, ND: -21.3 mL/m2, p=0.001). Other indices of remodeling showed similar behavior (Table). 
Rate of death and HF hospitalization were similar in D and ND (p=NS).
Conclusions: Diabetics with NYHA class I-II HF have an attenuated reverse remodeling response to CRT, yet clinical outcomes are similar between 
D and ND.
Table. Reverse remodeling with CRT in D and ND. 
Measure
D
mean (95% CI)
ND
mean (95% CI)
Difference
D-ND
(95% CI)
p-value Adjusted p-value
ΔLVESVI (mL/m2) -8.9 (-15.1, -2.6) -21.3 (-24.7, -17.9) 12.4 (5.3, 19.5) 0.001 0.001
ΔLVEDVI (mL/m2) -8.8 (-15.7, -1.8) -22.7 (-26.4, -18.9) 13.9 (6, 21.8) 0.001 0.001
ΔLVEDD (cm) -0.11 (-0.33, 0.1) -0.41 (-0.53, -0.3) 0.3 (0.06, 0.54) 0.015 0.012
ΔLVESD (cm) 0.05 (-0.21, 0.31) -0.54 (-0.68, -0.4) 0.59 (0.3, 0.88) < 0.001 < 0.001
ΔLVEDV (mL) -17 (-31, -3) -41.1 (-48.7, -33.4) 24.1 (8.1, 40) 0.003 0.003
ΔLVESV (mL) -17.5 (-29.8, -5.2) -39.3 (-46.1, -32.6) 21.8 (7.8, 35.9) 0.002 0.002
ΔLVEF (%) 2.5 (0.5, 4.5) 5.1 (4.1, 6.2) -2.6 (-4.9, -0.4) 0.023 0.026
